Contemporary trends in extent of surgery for differentiated thyroid cancer with extrathyroidal extension

Am J Surg. 2024 Feb:228:173-179. doi: 10.1016/j.amjsurg.2023.09.021. Epub 2023 Sep 15.

Abstract

Objective: Although lobectomy is acceptable for patients with small, low-risk differentiated thyroid cancer (DTC), gross extrathyroidal extension (ETE) remains an indication for total thyroidectomy (TT). Here we investigate evolving trends in extent of surgery for ​+ ​ETE DTC.

Methods: Patients with +ETE DTC who underwent resection from 2010 to 2020 were identified using the National Cancer Database. The primary outcome was performance of TT versus lobectomy.

Results: Among 5851 patients, most were female (79.7%), white (80.0%), and had minimal ETE (91.8%). Ninety-two percent of patients received TT. Year of treatment was influential (p ​< ​0.001), with increasing lobectomy rates in later years. On multivariable analyses, a decreased likelihood of TT was seen in years 2015 through 2020.

Conclusions: Most patients with +ETE DTC underwent guideline-concordant TT, but lobectomy rates doubled over the study period. These findings may reflect increased preference for lobectomy in low-risk DTC, but could undertreat patients with high-risk features.

Keywords: Differentiated thyroid cancer; Extent of surgery; Extrathyroidal extension; Lobectomy; Thyroidectomy.

MeSH terms

  • Adenocarcinoma* / surgery
  • Female
  • Humans
  • Male
  • Neoplasm Recurrence, Local / surgery
  • Retrospective Studies
  • Risk Factors
  • Thyroid Neoplasms* / surgery
  • Thyroidectomy